Ignite Creation Date:
2025-12-24 @ 7:37 PM
Ignite Modification Date:
2026-02-19 @ 8:23 PM
Study NCT ID:
NCT03769103
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-10-31
First Post:
2018-12-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC
Sponsor:
British Columbia Cancer Agency
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-19
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-04
Completion Date Type:
ESTIMATED
First Submit Date:
2018-12-03
First Submit QC Date:
None
Study First Post Date:
2018-12-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-29
Last Update Post Date:
2024-10-31
Last Update Post Date Type:
ACTUAL